Cowen Downgrades Celldex Therapeutics (CLDX) to Market Perform

Go back to Cowen Downgrades Celldex Therapeutics (CLDX) to Market Perform

Form 8-K Celldex Therapeutics, For: Apr 16

April 16, 2018 7:01 AM EDT

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________

Form 8-K
_____________________

CURRENT REPORT

Pursuant to Section 13 or... More